Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
crispr-cas9
life sciences
national blog main
national top stories
akcea therapeutics
alnylam pharmaceuticals
biology
biotech
boston
cancer
crispr
crispr therapeutics
drugs
editas
editas medicine
emerging tech
endeavor
european medicines agency
fda
fundings & exits
gene editing
harvard pilgrim health care
health
hereditary transthyretin amyloidosis
hiv
inotersen
institute for clinical and economic review
intellia therapeutics
national
new york blog main
new york top stories
news
onpattro
p53
patisiran
peter diamandis
pfizer
san diego blog main
What
cells
5
×
gene
5
×
medicine
5
×
new
cas
crispr
editing
genetic
human
researchers
today
university
allows
alnylam
angeles
approach
approves
biological
biopharmaceutical
body
california
called
cancer
cardiologists
celgene
celularity
clear
closer
company
creating
cure
day
defect
derived
described
developed
diamandis
diego
dormant
drive
Language
unset
Current search:
cells
×
gene
×
medicine
×
@digitaltrends.com
4 years ago
CRISPR-Cas9 gene editing could one day ‘turn off’ HIV virus in the body
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
@theverge.com
9 years ago
Scientists are one step closer to replacing mechanical pacemakers with biological ones